Skip to content
healthcare.dev
Get a free key

Irritable Bowel Syndrome Therapy

NDC 17312-019, ASAFETIDA - BISMUTH SUBNITRATE - BRYONIA ALBA ROOT - ACTIVATED CHARCOAL - LYCOPODIUM CLAVATUM SPORE - SODIUM CARBONATE - STRYCHNOS NUX-VOMICA SEED - VERATRUM ALBUM ROOT -, tablet, orally disintegrating, from TRP Company.

Product NDC
17312-019
Status
Listed
Labeler
TRP Company
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17312-019 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASAFETIDA3 [hp_X]/1
  • BISMUTH SUBNITRATE6 [hp_X]/1
  • BRYONIA ALBA ROOT6 [hp_X]/1
  • ACTIVATED CHARCOAL6 [hp_X]/1
  • LYCOPODIUM CLAVATUM SPORE6 [hp_X]/1
  • SODIUM CARBONATE6 [hp_X]/1
  • STRYCHNOS NUX-VOMICA SEED6 [hp_X]/1
  • VERATRUM ALBUM ROOT6 [hp_X]/1

Pharmacologic classes

Allergens [CS]; Bismuth [CS]; Bismuth [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]

Package NDCNDC-11Package
17312-019-14173120019141 BOTTLE in 1 PACKAGE (17312-019-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17312-019 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17312-019 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17312-019. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.